Vote Scores
Filings read through

Supernus Pharmaceuticals, Inc.: how funds voted at the meeting of 16 Jun 2025

Ticker
SUPN
Meeting
Season
year to 30 June 2025
Filers reporting
435
Ballot items
4

435 filers on Form N-PX reported votes at the Supernus Pharmaceuticals, Inc. meeting of 16 Jun 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Supernus Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 92.3% of the reported votes are for. 26 filers withheld from or voted against at least one nominee.

    618 vote records from 156 filers. 2 of the 155 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 41 fund families
    • For 37
    • Abstain or withhold 1
    • Split or no vote 3
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    637 vote records from 430 filers. 24 of the 420 filers that marked the item voted against management. 10 filers gave no management mark.

    • Positions of 46 fund families
    • For 46
  3. Item 3: Audit-related items (auditor ratification)

    309 vote records from 156 filers. 6 of the 155 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 41 fund families
    • For 41
  4. Item 4: To consider and vote upon a stockholder proposal, if included in our Proxy Statement for the Annual...

    102 vote records from 57 filers. 26 of the 36 filers that marked the item voted against management. 21 filers gave no management mark.

    • Positions of 15 fund families
    • Against 1
    • Abstain or withhold 14
    • Against management 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Supernus Pharmaceuticals, Inc., meeting of 16 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor4. Proposal
AllianceBernsteinForNo reportNo report
AllspringForNo reportNo report
American BeaconForForNo report
American CenturyForForNo report
BlackRock and iSharesForForAbstain, against management
BNY MellonForForNo report
Brighthouse FundsForForNo report
Charles SchwabForForAbstain
Columbia ThreadneedleForForNo report
DimensionalForNo reportNo report
DWSForForNo report
EquitableForForNo report
Federated HermesForForAbstain
FidelityForForNo report
First TrustForForNo report
Franklin TempletonForForNo report
Global XForForNo report
Goldman SachsForForAbstain, against management
Guggenheim and RydexForForNo report
InvescoForForNo report
J.P. MorganForForAbstain, against management
Jackson National fundsForForAbstain, against management
John Hancock and ManulifeForForAbstain, against management
Lincoln FinancialForForNo report
Macquarie and Delaware FundsForForNo report
MassMutualForNo reportNo report
Morgan Stanley, Eaton Vance and CalvertForForNo report
NationwideForForAbstain
Natixis and Loomis SaylesForForAbstain, against management
Neuberger BermanForNo reportNo report
Northern Trust and FlexSharesForForNo report
Nuveen and TIAAForForNo report
Pacific Life fundsForForNo report
PGIM and PrudentialForForAbstain
PrincipalForForAbstain
ProShares and ProFundsForForNo report
Russell InvestmentsForForAgainst
SEIForForAbstain
State Street and SPDRForForNo report
T. Rowe PriceForForNo report
ThriventForForNo report
TransamericaForForAbstain
VanguardForForAbstain
Victory CapitalForForNo report
VoyaForForNo report
WisdomTreeForForNo report

Questions

How many filers reported votes at the Supernus Pharmaceuticals, Inc. meeting?
435 Form N-PX filers reported votes at the meeting of 16 Jun 2025. On say-on-pay, 24 of 420 filers that marked the item voted against management (5.7%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Supernus Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Supernus Pharmaceuticals, Inc. with a meeting date within three days of 16 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .